1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EV-301: An open-label, randomized phase III study to evaluate enfortumab vedotin versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (la/mUC)
    Meeting Abstract

    Petrylak, D. P.; Rosenberg, J.; Duran, I.; Loriot, Y.; Sonpavde, G.; Wu, C.; Gartner, E.; Melhem-Bertrandt, A.; Powles, T.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression and T-cell inflamed gene expression profile (GEP) in Korean and US patients (pts) with advanced gastric cancer (GC)
    Meeting Abstract

    Rha, S. Y.; Ku, G. Y.; Kim, H. S.; Chung, H. C.; Amlashi, F. G.; Maru, D. M.; Fein, C.; Tang, L.; Savage, M. J.; Zhou, W.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Phase I study of the AXL inhibitor DS-1205c in combination with osimertinib in subjects with metastatic or unresectable EGFR-mutant NSCLC
    Meeting Abstract

    Planchard, D.; Janne, P. A.; Yu, H. A.; Moro-Sibilot, D.; Goldberg, T.; Gu, X.; Li, J.; McGill, J.; Yu, C.; Slosberg, E.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Subgroup analysis of rucaparib in platinum-sensitive recurrent ovarian carcinoma: Effect of prior chemotherapy regimens in ARIEL3
    Meeting Abstract

    Lorusso, D.; Coleman, R. L.; Oza, A. M.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy
    Meeting Abstract

    Naing, A.; Autio, K. A.; Falchook, G. S.; Meric-Bernstam, F.; Litton, J. K.; Ibrahim, N. K.; Hung, A.; Oft, M.; Leveque, J.; Patel, M. R.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • CTC-based biomarkers & PSMA-targeted imaging in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Vogelzang, N. J.; Sartor, O.; Armour, A.; Messmann, R.; Groaning, M.; Robarts, A.; Tolcher, A. W.; Gordon, M.; Babiker, H. M.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Prospective validation of prognostic scores to improve patient selection for immuno-oncology trials
    Meeting Abstract

    Massard, C.; Segal, N. H.; Cho, D. C.; Papadimitrakopoulou, V. A.; Rizvi, N. A.; Cho, B. C.; Yu, L.; Yang, H.; Hsieh, H. J.; Zhang, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes by baseline alpha-fetoprotein (AFP) levels in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Kelley, R. K.; El-Khoueiry, A. B.; Meyer, T.; Rimassa, L.; Merle, P.; Chan, S. L.; Tran, A.; Parnis, F.; Tam, V. C.; Cattan, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
    Meeting Abstract

    Lacouture, M.; Dion, H.; Ravipaty, S.; Akmaev, V. R.; Sarangarajan, R.; Jimenez, J. J.; Narain, N. R.; Berman, B.; Goldfarb, S.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950)
    Meeting Abstract

    Jones, R. L.; Blay, J. Y.; Agulnik, M.; Chugh, R.; Mir, O.; Italiano, A.; Thomas, D.; Gupta, A.; Jahan, T.; Cote, G.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save